These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medical therapy of neurocardiogenic syncope. Cadman CS Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106 [TBL] [Abstract][Full Text] [Related]
3. Strategy for the management of vasovagal syncope. Bloomfield DM Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777 [TBL] [Abstract][Full Text] [Related]
4. Neurocardiogenic syncope in children : current concepts in diagnosis and management. Massin M Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219 [TBL] [Abstract][Full Text] [Related]
9. A review of pathophysiology and therapy of patients with vasovagal syncope. White CM; Tsikouris JP Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294 [TBL] [Abstract][Full Text] [Related]
10. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720 [TBL] [Abstract][Full Text] [Related]
11. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Grubb BP; Kosinski D; Mouhaffel A; Pothoulakis A Pacing Clin Electrophysiol; 1996 May; 19(5):836-40. PubMed ID: 8734752 [TBL] [Abstract][Full Text] [Related]
12. [Pharma-clinics. How I treat vasovagal syncope]. Kulbertus H; Melon P Rev Med Liege; 1999 Jun; 54(6):510-3. PubMed ID: 10446518 [TBL] [Abstract][Full Text] [Related]
13. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists. Klingenheben T; Kalusche D; Li YG; Schöpperl M; Hohnloser SH J Cardiovasc Electrophysiol; 1996 Sep; 7(9):802-8. PubMed ID: 8884509 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of neurocardiogenic syncope. Grubb BP; Karas B Curr Opin Cardiol; 1998 Jan; 13(1):29-35. PubMed ID: 9559254 [TBL] [Abstract][Full Text] [Related]
15. Is this form of syncope to blame? Porr WA RN; 2004 Jun; 67(6):32-5. PubMed ID: 15317281 [No Abstract] [Full Text] [Related]
16. What can I do when first-line measures are not enough for vasovagal syncope? Hutt Centeno E; Mayuga KA Cleve Clin J Med; 2018 Dec; 85(12):920-922. PubMed ID: 30526751 [No Abstract] [Full Text] [Related]
17. Dysautonomia and neurocardiogenic syncope. McLeod KA Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639 [TBL] [Abstract][Full Text] [Related]
18. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope. Lafuente EA; Martínez LC; Moguel JO; David RN; García JD; Tejeda AO; Reyes PH; González VR Arch Med Res; 2004; 35(5):416-20. PubMed ID: 15610912 [TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis. Raj P; Lei L; Flevaris P; Raj S; Sheldon R Clin Auton Res; 2023 Dec; 33(6):811-819. PubMed ID: 37971641 [TBL] [Abstract][Full Text] [Related]